Market Reports Center One Stop Market Reaserch Shop Endometriosis Drugs Market Share, Size, Global Insights, Emerging Trends, Growth Drivers and Future Outlook: Market Reports Center Summary Technavio Announces the Publication of its Research Report – Global Endometriosis Market 2016-2020 Technavio recognizes the following companies as the key players in the global endometriosis market: AbbVie, AstraZeneca, Bayer HealthCare, and Pfizer. Other Prominent Vendors in the market are: Addex Therapeutics, Astellas Pharma, Debiopharm, ElexoPharm, Endoceutics, Euroscreen, Forendo Pharma, Isifer, Kissei Pharmaceutical, Neurocrine Biosciences, Nippon Shinyaku, ObsEva, Orphagen Pharmaceuticals, Philogen, PregLem, Repros Therapeutics, Roivant Sciences, SK Chemicals, Speciality European Pharma, SYNG Pharmaceuticals, Takeda, United Pharmaceuticals, and ValiPharma. Commenting on the report, an analyst from Technavio’ s team said: “A trend boosting market growth is the increased focus on IUDs. Current treatment for endometriosis includes the use of GnRH agonists and oral contraceptives along with the use of surgeries. However, all these therapies are associated with many unwanted side effects due to hormonal changes in the body along with the early recurrence of the disease. Hence, the need for an effective replacement for these conventional therapies has led to the development of IUDs. Though IUDs were initially developed for effective birth control, their use has been extended to treat endometriosis. Levonorgestrel intrauterine system (LNG-IUS) devices such as Mirena and Skyla will release progestogen into the body through the IUD at low concentration for an extended period.” ” Browse Detail Report With TOC @ https://marketreportscenter.com/reports/319902/global-endometriosis-drugs-market-2016-2020 Market Reports Center One Stop Market Reaserch Shop According to the report, a key growth driver is the increased adoption of OCPs. OCPs also referred to as hormonal pills contain the female hormones, estrogen and progestin similar to that produced by the ovaries. Some of the pills may contain only progestin. Apart from being used as contraceptives, these hormone pills are found to be effective in treating endometriosis. They do not cure endometriosis but are helpful in controlling the pain and preventing the condition from worsening. These medicines are also found to lower the chances of getting endometrial and ovarian cancer, ovarian cysts, certain breast lumps, and also protects the individual from osteoporosis. Further, the report states that one challenge that could hamper market growth is surgery as the primary treatment option. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. About the Endometriosis Market Endometriosis is a common health condition in women where the endometrial tissue, which is found in the lining of the uterus, appears and grows outside the uterine cavity. The endometrial tissue is shed from the body during menstruation. The tissue growing outside the uterine cavity is called endometrial implants. Endometriosis can also occur in the fallopian tubes, ovaries, pelvic cavity, vagina, cervix, and bladder. In rare cases, it has been reported in other parts of the body such as the lungs, brain, and skin. These implants are usually benign in nature. Women of reproductive age are often affected by this condition. Endometriosis often occurs due to retrograde menstruation, where the menstrual blood flows back into the pelvic cavity instead of leaving the body. This then adheres to the surface of the bladder, ovaries, or rectum and continues to grow or thicken over the course of each menstrual cycle. Technavio’ s analysts forecast the global endometriosis market to grow at a CAGR of 2.05% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global endometriosis market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of approved and off-label branded and generic drugs used for the treatment and prevention of endometriosis and related pain. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period. The market is divided into the following segments based on geography: • Americas • APAC Market Reports Center One Stop Market Reaserch Shop • EMEA Technavio's report, Global Endometriosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • AbbVie • AstraZeneca • Bayer HealthCare • Pfizer Other prominent vendors • Addex Therapeutics • Astellas Pharma • Debiopharm • ElexoPharm • Endoceutics • Euroscreen • Forendo Pharma • Isifer • Kissei Pharmaceutical • Neurocrine Biosciences • Nippon Shinyaku • ObsEva • Orphagen Pharmaceuticals • Philogen • PregLem • Repros Therapeutics • Roivant Sciences • SK Chemicals • Speciality European Pharma • SYNG Pharmaceuticals • Takeda • United Pharmaceuticals • ValiPharma Market driver • Increased adoption of OCPs • For a full, detailed list, view our report Market challenge • Surgeries as primary treatment option Market Reports Center One Stop Market Reaserch Shop • For a full, detailed list, view our report Market trend • Increased focus on intrauterine devices (IUDs) • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’ s time when you purchase this market report. Details are provided within the report. Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/319902 Table of Content PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Endometriosis: An overview PART 05: Pipeline analysis • Pipeline molecules based on their mechanism PART 06: Key buying criteria for endometriosis drugs PART 07: Market landscape • Market overview • Five forces analysis PART 08: Market segmentation by type of therapy • Hormone therapy • Market size and forecast • Pain medications • Market size and forecast PART 09: Market segmentation by ROA Market Reports Center One Stop Market Reaserch Shop • Oral • Parenteral • Intrauterine systems • Nasal spray PART 10: Geographical segmentation • Global endometriosis drugs market by geography 2015-2020 • Endometriosis drugs market in Americas • Endometriosis drugs market in EMEA • Endometriosis drugs market in APAC To Get Discount On The Report @ https://marketreportscenter.com/request-discount/319902 About Us: Market Reports Centeris an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable. Market Reports Center currently has more than 1,20,000 plus titles and 30+ Publishers on our platform and growing consistently. We cover more than 35 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Construction, Agriculture, Food, Beverages, Banking & Finance, Media and Government, Public Sector Studies. Contact Information: Sam Collins Market Reports Center 1-646-883-3044 (US) [email protected] https://marketreportscenter.com
According to the report, a key growth driver is the increased adoption of OCPs. OCPs also referred to as hormonal pills contain the female hormones, estrogen and progestin similar to that produced by the ovaries. Some of the pills may contain only progestin
© Copyright 2024 Paperzz
